参考文献/References:
[1]MANNES P Z,ADAMS T S,FARSIJANI S,et al.Noninvasive assessment of the lung inflammation-fibrosis axis by targeted imaging of CMKLR1[J].Sci Adv,2024,10(25):m9817.
[2]张玉,游如旭,张聪,等.骨质疏松症治疗药物合理应用专家共识(2023)[J].中国医院药学杂志,2024,44(9):985-1006.
[3]MESSINA R,GUGGINO G,BENFANTE A,et al.Interstitial lung disease in elderly rheumatoid arthritis patients[J].Drugs Aging,2020,37(1):11-18.
[4]KHOR Y H,GLASPOLE I,GOH N.Therapeutic burden in interstitial lung disease:Lessons to learn[J].Respirology,2019,24(6):566-571.
[5]YU K H,CHEN H H,CHENG T T,et al.Consensus recommendations on managing the selected comorbidities including cardiovascular disease,osteoporosis,and interstitial lung disease in rheumatoid arthritis[J].Medicine (Baltimore),2022,101(1):e28501.
[6]曾梓苑,陈生,黄俊浩,等.国医大师晁恩祥运用养阴益气法治疗肺痿经验[J].陕西中医,2022,43(10):1442-1444.
[7]刘尚尚,叶国庆,耿燕慧,等.中医药介导相关信号通路治疗骨质疏松症研究进展[J].陕西中医,2025,46(3):428-432.
[8]朱文,李叶卉,汪悦.基于“极热伤络”理论的结缔组织病相关肺间质病变的分期证治探讨[J].时珍国医国药,2022,33(4):1025-1026.
[9]黄潇雅,刘荣奎,李雯,等.基于“肺热论”辨治特发性肺纤维化[J].环球中医药,2022,15(8):1431-1434.
[10]于睿智,吕晓东,庞立健,等.刍议清络法论治特发性肺纤维化急性发作[J].世界科学技术-中医药现代化,2021,23(11):4305-4309.
[11]曹盼举,张晓刚,于海洋,等.基于《内经》“肺热叶焦,则生痿躄”理论探讨肺与骨质疏松症之间的关系[J].中国骨质疏松杂志,2019,25(5):709-712.
[12]陈宏,张伟,郭建波,等.地龙提取物通过抑制TGF-β1信号通路发挥抗肺纤维化作用研究[J].陕西中医,2021,42(4):427-429.
[13]李瑞萍,宋伟,王一然.清燥救肺汤联合泼尼松及钙立得治疗肺癌放射性肺损伤疗效及对动脉血氧分压和血清CRP、TGF-β1水平的影响[J].现代中西医结合杂志,2019,28(3):308-310.
[14]林泽晨,吴旭萍,林胜友.加味麻杏石甘汤对放射性肺纤维化转化生长因子β/Smad信号通路调控的影响[J].中华危重症医学杂志(电子版),2018,11(6):403-406.
[15]WANG Q L,LI H F,WANG D P,et al.Effect of GGCX on the differentiation function of osteoporosis bone marrow mesenchymal stem cells through regulating TGF-β/smad signaling pathway[J].Eur Rev Med Pharmacol Sci,2019,23(17):7224-7231.
[16]HONG S,CHA K H,PARK J H,et al.Cinnamic acid suppresses bone loss via induction of osteoblast differentiation with alteration of gut microbiota[J].J Nutr Biochem,2022,101:108900.
[17]王尽欢,刘军彤,石岩,等.痿证中医病因病机理论框架结构研究[J].辽宁中医药大学学报,2023,25(12):162-165.
[18]HAO Y,BAKER D,TEN D P.TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis[J].Int J Mol Sci,2019,20(11):2767.
[19]王文龙.基于上皮间质转化探讨复方苦参注射液防治放射性肺损伤的机制[D].武汉:湖北中医药大学,2020.
[20]FRANGOGIANNIS N.Transforming growth factor-β in tissue fibrosis[J].J Exp Med,2020,217(3):e20190103.
[21]ZHANG T,WANG X F,WANG Z C,et al.Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation[J].Biomed Pharmacother,2020,129:110287.
[22]TZAVLAKI K,MOUSTAKAS A.TGF-β signaling[J].Biomolecules,2020,10(3):487.
[23]HETTIARACHCHI S U,LI Y H,ROY J,et al.Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models[J].Sci Transl Med,2020,12(567):186-189.
[24]HU H H,CHEN D Q,WANG Y N,et al.New insights into TGF-β/Smad signaling in tissue fibrosis[J].Chem Biol Interact,2018,292:76-83.
[25]LI X,MA L,HUANG K,et al.Regorafenib-attenuated,bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway[J].Int J Mol Sci,2021,22(4):1985.
[26]陶旺,王培屹,孙杰,等.基于伏邪理论从“寒热-痰瘀-虚劳”角度分期辨治肺痿[J].世界中医药,2024,19(8):1129-1133.
[27]WANG W,CHEN S,XU S,et al.Jianpi Shengqing Huazhuo formula improves abnormal glucose and lipid metabolism in obesity by regulating mitochondrial biogenesis[J].J Ethnopharmacol,2024,319(Pt 1):117102.
[28]马悦宁,郭思佳,李云辉,等.丹龙口服液对肺纤维化模型小鼠TGF-β1/Smads信号通路关键分子表达水平的影响[J].辽宁中医杂志,2025,52(6):204-207.
[29]于睿智,王天娇,臧凝子,等.清络饮调控TGF-β1/Smads信号传导通路干预大鼠特发性肺纤维化急性加重[J].中华中医药杂志,2024,39(7):3669-3674.
[30]段妍君,张新悦,吕文亮,等.基于TGF-β1/Smad信号通路的新冠康复颗粒对肺纤维化早期大鼠上皮间质转化的影响研究[J].时珍国医国药,2023,34(12):2892-2895.
[31]张绍良,王晨玫,张蕾,等.从阴火论治自身免疫病[J].中华中医药杂志,2024,39(7):3505-3508.
[32]施侠威,沈悦倩,邵婧怡,等.徐志瑛从《难经》“肺熟”理论辨治特发性肺纤维化思路探析[J].中华中医药杂志,2021,36(8):4714-4717.
[33]田丽,张伟.基于“阳化气,阴成形”理论的肺间质纤维化发病机制及治疗探讨[J].时珍国医国药,2019,30(3):647-648.
[34]GHAFOURI-FARD S,ASKARI A,SHOOREI H,et al.Antioxidant therapy against TGF-β/SMAD pathway involved in organ fibrosis[J].J Cell Mol Med,2024,28(2):e18052.
[35]TANG C,LIANG D,QIU Y,et al.Omentin-1 induces osteoblast viability and differentiation via the TGF-β/Smad signaling pathway in osteoporosis[J].Mol Med Rep,2022,25(4):132.
[36]GINGERY A,BRADLEY E W,PEDERSON L,et al.TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival[J].Exp Cell Res,2008,314(15):2725-2738.
[37]王凯,宋敏,文皓楠,等.转化生长因子-β在骨代谢中作用机制的研究进展[J].中国骨质疏松杂志,2020,26(2):308-312.
[38]LIU J,ZHANG J,LIN X,et al.Age-associated callus senescent cells produce TGF-β1 that inhibits fracture healing in aged mice[J].J Clin Invest,2022,132(8):e148073.
[39]ZOU M L,CHEN Z H,TENG Y Y,et al.The Smad dependent TGF-β and BMP signaling pathway in bone remodeling and therapies[J].Front Mol Biosci,2021,8:593310.
[40]金鑫艳,陈文辉,李双蕾,等.从阴血不足探讨酸枣仁汤合用百合地黄汤治疗绝经后骨质疏松症的机理[J].北京中医药大学学报,2022,45(1):87-91.
[41]张体华,刘鑫.知母皂苷对糖尿病肾病大鼠的肾保护作用及机制[J].中国老年学杂志,2024,44(10):2439-2443.
[42]黄定根,邓雪峰,吴雅丽,等.鱼腥草挥发油对去卵巢小鼠骨质疏松的预防作用及机制研究[J].中南药学,2019,17(1):25-29.
[43]赵军,师建平.蒙药蓝刺头对去卵巢骨质疏松大鼠TGF-β1、UI、BMD的作用[J].西部中医药,2022,35(7):16-19.
相似文献/References:
[1]成 洁,王 颖△,吉健华,等.骨疏康胶囊治疗肾阳虚型骨质疏松症疗效及对患者骨代谢影响*[J].陕西中医,2019,(9):1232.
CHENG Jie,WANG Ying,JI Jianhua,et al.Effect of Gushukang capsule on the treatment of Shenyangxu osteoporosis and effect on bone metabolism[J].,2019,(3):1232.
[2]刘 峰,孙庆山,白田雨.温肾强骨方对肿瘤中后期并发骨质疏松症患者骨密度、骨形成及骨吸收的影响[J].陕西中医,2021,(6):712.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.008]
LIU Feng,SUN Qingshan,BAI Tianyu.Effects of Wenshen Qianggu recipe on bone mineral density bone formation and bone resorption in patients with osteoporosis complicated in the middle and late stage of tumor[J].,2021,(3):712.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.008]
[3]程文娟,马战平.马战平应用“扶正祛邪”法分期论治间质性肺病经验[J].陕西中医,2022,(3):348.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.019]
[4]吴 雪,张惜燕,李翠娟,等.固本活血壮骨颗粒通过Wnt/LRP5/β-catenin信号通路改善糖皮质激素性骨质疏松症机制研究[J].陕西中医,2023,(12):1693.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.006]
WU Xue,ZHANG Xiyan,LI Cuijuan,et al.Mechanism of Guben Huoxue Zhuanggu granule improving glucocorticoid-induced osteoporosis through Wnt/LRP5/β-catenin signaling pathway[J].,2023,(3):1693.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.006]
[5]刘尚尚,叶国庆,耿燕慧,等.中医药介导相关信号通路治疗骨质疏松症研究进展[J].陕西中医,2025,46(3):428.[doi:DOI:10.3969/j.issn.1000-7369.2025.03.031]
LIU Shangshang,YE Guoqing,GENG Yanhui,et al.Research progress of traditional Chinese medicine-mediated related signaling pathways in treatment of osteoporosis[J].,2025,46(3):428.[doi:DOI:10.3969/j.issn.1000-7369.2025.03.031]